3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Myelofibrosis
24
Leukemia, Myeloid, Acute
16
Myeloproliferative Disorders
15
Polycythemia Vera
12
Leukemia
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Myelodysplastic Syndromes
9
Thrombocythemia, Essential
8
Graft vs Host Disease
8
Recurrence
6
Neoplasms
6
Myelodysplastic-Myeloproliferative Diseases
4
Lymphoma, T-Cell
4
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Breast Neoplasms
4
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Lymphoma, T-Cell, Cutaneous
3
Leukemia, Prolymphocytic, T-Cell
3
Leukemia, Myelomonocytic, Chronic
3
Hematologic Neoplasms
3
Glioblastoma
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Bronchiolitis Obliterans Syndrome
3
Triple Negative Breast Neoplasms
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Interventions
Fulvestrant
5
serabelisib
2
sapanisertib
2
ribociclib
2
palbociclib
2
Paclitaxel
2
Letrozole
2
Irinotecan
2
Gemcitabine
2
Carboplatin
2
Alpelisib
2
venetoclax
1
tivozanib
1
tipifarnib
1
sotorasib
1
pembrolizumab
1
olaparib
1
niraparib
1
lorlatinib
1
liposomal doxorubicin
1
inavolisib
1
exemestane
1
encorafenib
1
ceralasertib
1
cemiplimab
1
capivasertib
1
binimetinib
1
abemaciclib
1
Taxes
1
Tamoxifen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hereditary Sensory and Autonomic Neuropathies
×
ruxolitinib
×
1 year
×
Clear all
No trials found.